PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12670906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.

  2001cited by this paper
• Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors

  2001influential reference
• A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate.

  2000influential reference
• Ab initio gene finding in Drosophila genomic DNA.

  2000cited by this paper
• G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.

  1999cited by this paper
• High density synthetic oligonucleotide arrays

  1999cited by this paper
• Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

  1999cited by this paper
• Multiple transcriptional variants and RNA editing in C18orf1, a novel gene with LDLRA and transmembrane domains on 18p11.2.

  1998cited by this paper
• Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells.

  1998cited by this paper
• Dpc4 transcriptional activation and dysfunction in cancer cells.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Expression monitoring by hybridization to high-density oligonucleotide arrays

  1996cited by this paper
• MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

  1996cited by this paper
• Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

  1995cited by this paper
• Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients.

  1995cited by this paper
• Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*)

  1995cited by this paper
• Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.

  1995cited by this paper
• A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.

  1995cited by this paper
• Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.

  1994cited by this paper
• Loss of receptors for transforming growth factor beta in human T-cell malignancies.

  1994cited by this paper
• Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor.

  1994cited by this paper
• Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.

  1994cited by this paper
• Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells

  1994cited by this paper
• Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.

  1993cited by this paper
• TGF-beta expression in the human colon: differential immunostaining along crypt epithelium.

  1993cited by this paper
• Development of resistance mechanisms to the growth‐inhibitory effects of transforming growth factor-β during tumor progression

  1993cited by this paper
• Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses.

  1992cited by this paper
• TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector

  1992cited by this paper
• Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest

  1991cited by this paper
• Expression of transforming growth factor beta 1 by human endometrial carcinoma cell lines: inverse correlation with effects on growth rate and morphology.

  1990cited by this paper
• Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.

  1990cited by this paper
• Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1.

  1989cited by this paper
• Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells.

  1988cited by this paper
• Cell culture of human colon adenomas and carcinomas.

  1987cited by this paper
• Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factor.

  1987cited by this paper
• Establishment and characterization of human colorectal cancer cell lines.

  1984cited by this paper

• In Vitro Analysis of PMEPA1 Upregulation in Mesenchymal Stem Cells Induced by Prostate Cancer Cells

  2025cites this paper
• Targeting Tumorigenic Coactivators in the PI3K/AKT Signaling Pathway: A Novel Approach for Cancer Treatment

  2025cites this paper
• Enhancer-driven gene regulatory networks reveal transcription factors governing T cell adaptation and differentiation in the tumor microenvironment.

  2025cites this paper
• Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity.

  2025cites this paper
• Distinct microglial transcriptomic signatures within the hippocampus

  2024cites this paper
• Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC

  2024cites this paper
• TMEPAI promotes degradation of the NF-κB signaling pathway inhibitory protein IκBα and contributes to tumorigenesis.

  2023cites this paper
• Prostate transmembrane androgen inducible protein 1 (PMEPA1): regulation and clinical implications

  2023cites this paper
• The strategic involvement of IRS in cancer progression.

  2023cites this paper
• Cyclooxygenase 2 Effector Genes as Potential Inflammation-Related Biomarkers for Colorectal Cancer Circulating Tumor Cells Detection by Liquid Biopsy

  2022cites this paper
• SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis

  2022cites this paper
• Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects.

  2022cites this paper
• A network of transcription factors governs the dynamics of NODAL/Activin transcriptional responses

  2022cites this paper
• Distinct functions of transforming growth factor-β signaling in c-MYC driven hepatocellular carcinoma initiation and progression

  2021cites this paper
• Diagnostic and therapeutic values of PMEPA1 and its correlation with tumor immunity in pan-cancer.

  2021cites this paper
• Sex Hormones and Lung Inflammation.

  2021cites this paper
• Surface topography is a context-dependent activator of TGF-β signaling in mesenchymal stem cells

  2020cites this paper
• TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel

  2020cites this paper
• Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer

  2020cites this paper
• TMEPAI/PMEPA1 Is a Positive Regulator of Skeletal Muscle Mass

  2020cites this paper
• PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer

  2020cites this paper
• Mechanotransduction is a context-dependent activator of TGF-β signaling in mesenchymal stem cells.

  2020cites this paper
• Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

  2020cites this paper
• PMEPA1/TMEPAI isoforms function via its PY and Smad‐interaction motifs for tumorigenic activities of breast cancer cells

  2020influential citation
• Prostate transmembrane protein androgen induced 1 is induced by activation of osteoclasts and regulates bone resorption

  2019cites this paper
• Prostaglandin F2α-induced Prostate Transmembrane Protein, Androgen Induced 1 mediates ovarian cancer progression increasing epithelial plasticity

  2019cites this paper
• PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1

  2019cites this paper
• Decreased sensitivity of several anticancer drugs in TMEPAI knockout triple-negative breast cancer cells

  2019cites this paper
• The TGF-β induced gene, PMEPA1, attenuates antitumor efficacy of aspirin in triple-negative breast cancer by regulating TGF-β1

  2019influential citation
• PMEPA1/TMEPAI knockout impairs tumour growth and lung metastasis in MDA-MB-231 cells without changing monolayer culture cell growth.

  2019cites this paper
• Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer

  2019cites this paper
• Development of Novel Monoclonal Antibodies for Evaluation of Transmembrane Prostate Androgen-Induced Protein 1 (TMEPAI) Expression Patterns in Gastric Cancer

  2018cites this paper
• TMEPAI family: involvement in regulation of multiple signalling pathways.

  2018cites this paper
• 2‐(2‐nitrobenzylidene) indolin‐3‐one compound inhibits transmembrane prostate androgen‐induced protein (TMEPAI) expression and cancer cell proliferation

  2018cites this paper
• Prostaglandin F2α-induced TGFβ-PMEPA1 pathway is a critical mediator of epithelial plasticity and ovarian carcinoma progression

  2018cites this paper
• Pmepa1 induced by RANKL‐p38 MAPK pathway has a novel role in osteoclastogenesis

  2018cites this paper
• Genome-Wide Analysis of Barrett's Adenocarcinoma. A First Step Towards Identifying Patients at Risk and Developing Therapeutic Paths12

  2017cites this paper
• Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway

  2017cites this paper
• Propofol inhibited invasion and decreased expression of PMEPA 1 in MDA-MB-231 cells

  2017cites this paper
• Sex differences in the development of prolactinoma in mice overexpressing hCGβ: role of TGFβ1.

  2017cites this paper
• TMEPAI increases lysosome stability and promotes autophagy.

  2016cites this paper
• PMEPA1, a TGF-β- and hypoxia-inducible gene that participates in hypoxic gene expression networks in solid tumors.

  2016cites this paper
• Transforming growth factor-beta increases breast cancer stem cell population partially through upregulating PMEPA1 expression.

  2016cites this paper
• Differentiation-inducing and anti-proliferative activities of isoliquiritigenin and all-trans-retinoic acid on B16F0 melanoma cells: Mechanisms profiling by RNA-seq.

  2016cites this paper
• Regulation of TGFβ/Smad signalling during early follicle development in the mouse ovary

  2016cites this paper
• Sp1 transcription factor promotes TMEPAI gene expression and contributes to cell proliferation

  2016cites this paper
• Genomic characterization of liver metastases from colorectal cancer patients

  2016cites this paper
• The Role of the C-Clamp in Wnt-Related Colorectal Cancers

  2016cites this paper
• The “ NF-ĸ B interacting long noncoding RNA” ( NKILA) transcript is antisense to cancer-associated gene PMEPA1

  2015cites this paper
• Common target genes of palatal and gingival fibroblasts for EMD: the microarray approach.

  2015cites this paper
• Cooperative induction of transmembrane prostate androgen induced protein TMEPAI/PMEPA1 by transforming growth factor-β and epidermal growth factor signaling.

  2015cites this paper
• Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN

  2015cites this paper
• Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.

  2015cites this paper
• ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer

  2015cites this paper
• Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival

  2015cites this paper
• TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells

  2014cites this paper
• TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer

  2014cites this paper
• Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer

  2014cites this paper
• C18 ORF1, a Novel Negative Regulator of Transforming Growth Factor-β Signaling*

  2014cites this paper
• The Role of miR-200b in Renal Fibrosis and Its in vivo Delivery Systems

  2014cites this paper
• Procédés pour classer un cancer comme sensible aux thérapies dirigées par tmepai et pour traiter ces cancers

  2014cites this paper
• INVESTIGATING THE NEDD4-MEDIATED UBIQUITINATION OF PMEPA1, AND ITS POTENTIAL ROLE IN THE REGULATION OF THE ANDROGEN RECEPTOR AS PART OF THE STEROID RESPONSE PATHWAY IN PROSTATIC CANCER

  2014cites this paper
• TMEPAI inhibits TGF-β signaling by promoting lysosome degradation of TGF-β receptor and contributes to lung cancer development.

  2014cites this paper
• Evaluation of Androgen Receptor Function in Prostate Cancer Prognosis and Therapeutic Stratification

  2014cites this paper
• КраТКие СооБщениЯ NEW MONOCLONAL ANTIBODY FOR TUMOR-ASSOCIATED PROTEIN PMEPA1 DETECTION

  2014cites this paper
• Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes

  2014influential citation
• TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer

  2014cites this paper
• Sex differences in the pituitary transforming growth factor-β1 system: studies in a model of resistant prolactinomas.

  2013cites this paper
• TMEPAI regulates EMT in lung cancer cells by modulating the ROS and IRS-1 signaling pathways.

  2013cites this paper
• Cellular responses to TGFβ and TGFβ receptor expression in human colonic epithelial cells require CaSR expression and function.

  2013cites this paper
• Implications of TGFβ on Transcriptome and Cellular Biofunctions of Palatal Mesenchyme

  2012cites this paper
• Altered responsiveness to TGF-β results in reduced Papss2 expression and alterations in the biomechanical properties of mouse articular cartilage

  2012cites this paper
• Caracterización del sistema TGF-ß1 hipofisario: en búsqueda de un blanco terapéutico para prolactinomas resistentes a agonistas dopaminérgicos

  2012cites this paper
• Molecular network pathways and functional analysis of tumor signatures associated with development of resistance to viral gene therapy

  2011cites this paper
• Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: a pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models.

  2011cites this paper
• PMEPA1 promotes androgen receptor‐negative prostate cell proliferation through suppressing the Smad3/4–c‐Myc–p21$^{{\rm Cip1}}$ signaling pathway

  2011cites this paper
• Requirement of TCF7L2 for TGF-β-dependent Transcriptional Activation of the TMEPAI Gene*

  2010cites this paper
• Application of T cell-based transcriptomics to identify three candidate biomarkers for monitoring anti-TGFβR therapy

  2010cites this paper
• Identification of Human Gene Products Containing Pro-Pro-x-Tyr (PY) Motifs that Enhance Glutathione and Endocytotic Marker Uptake in Yeast

  2010cites this paper
• Transforming growth factor-beta (TGF-beta)-inducible gene TMEPAI converts TGF-beta from a tumor suppressor to a tumor promoter in breast cancer.

  2010cites this paper
• TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling.

  2010cites this paper
• A Study of Genomic Modules and Intermodular Networks for Understanding the Operating System of Life

  2010cites this paper
• A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

  2009cites this paper
• A Feedback Loop between the Androgen Receptor and a NEDD4-binding Protein, PMEPA1, in Prostate Cancer Cells*

  2008cites this paper
• Ugene, a newly identified protein that is commonly overexpressed in cancer and binds uracil DNA glycosylase.

  2008cites this paper
• Transforming growth factor beta suppresses beta-catenin/Wnt signaling and stimulates an adhesion response in human colon carcinoma cells in a Smad4/DPC4 independent manner.

  2008cites this paper
• Switch of transforming growth factor beta function from tumor suppression to stimulation in adenomatous polyposis coli (APC) knocked-down human colon carcinoma cells.

  2008cites this paper
• High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone

  2007cites this paper
• A Role for DNA Methylation in Regulating the Growth Suppressor PMEPA1 Gene in Prostate Cancer

  2007cites this paper
• Role of transforming growth factor beta and Wnt signalling pathways in colon cancer

  2006cites this paper
• Cytokine Expression in Rat Colon During Postnatal Development: Regulation by Glucocorticoids

  2006cites this paper
• Preclinical Evaluation of Serine/Threonine Kinase Inhibitors Against Prostate Cancer Metastases

  2005cites this paper
• 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE IS A TGF-beta INDUCED SUPPRESSOR OF HUMAN COLORECTAL CANCER

  2005cites this paper
• Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.

  2005cites this paper
• Colorectal Cancer: Molecular Staging Models that Charactrize Risk and Enhance Prognosis.

  2004cites this paper
• Integration of human T‐cell leukemia virus type 1 in genes of leukemia cells of patients with adult T‐cell leukemia

  2004cites this paper
• PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.

  2003cites this paper
• Expression during Prostate Cancer Progression Exhibits Cell Growth Inhibitory Function and Decreased PMEPA 1 , an Androgen-regulated NEDD 4-binding Protein

  2003cites this paper
• Anticarcinogenic Properties of a Daidzein-Rich Fraction Isolated from Soybean

  2003cites this paper
• Review Article Transforming Growth Factor-beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression

  year unknowncites this paper